Project Grant HT9425261E290
Award Date 7/31/26
Completion Date 7/30/29
Dollars Obligated $1.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.19 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2025, through April 30, 2029. This four-year research initiative addresses toxicant-mediated pulmonary hypertension in Southwest Asia veterans, supporting advanced biomedical research designed to transform healthcare for military service members and...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $700,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2025, with a completion date of August 14, 2027. The award supports research investigating the DPEP1-neutrophil axis in microsatellite stable colorectal cancer, contributing to the DHA's broader mission of transforming healthcare for service members and the...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.26 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on toxicant-mediated pulmonary hypertension in Southwest Asia veterans. The four-year award, effective May 1, 2025 through April 30, 2029, supports biomedical research addressing health challenges relevant to military service members and veterans...
- Federal Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $2.39 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025, through July 31, 2029. The award funds biomedical research investigating the molecular basis of post-injury syndrome and mineralization disorders, with particular focus on decoding inflammatory mechanisms underlying these conditions. This research...
- Federal Project Grant Award Summary Vanderbilt University Medical Center (VUMC) received a $524,678 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for research on early-onset clear cell renal cell carcinoma as a clinically and genomically distinct variant. The award, obligated on September 30, 2026, supports a two-year research initiative through September 29, 2028, conducted at VUMC's Nashville, Tennessee location....
- Federal Grant Award Summary Vanderbilt University Medical Center received a $1,847,457 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2030. The grant supports "Building on the Foundation of the Academy of Kidney Cancer Investigators," a research initiative aimed at advancing biomedical research to transform healthcare for service members and the American public...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $560,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project titled "Fundamental Mechanisms of Wnt-Driven Metastasis." The award, issued July 1, 2026, with a completion date of June 30, 2028, supports basic biomedical research investigating the molecular mechanisms by which Wnt signaling drives metastatic cancer...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $1,267,303 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research initiative titled "Defining Chronic Immune-Related Adverse Events in Melanoma Survivors." The award, effective August 1, 2025, through July 31, 2028, supports hypothesis-driven biomedical research focused on understanding and...
- The University of Virginia received a $583,333 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 31, 2026, for the project "Optimizing Lung Cancer Screening Guidelines for All Americans." The award period extends through July 30, 2029, with performance conducted at the university's Charlottesville, Virginia location. This project delivers biomedical research services focused on advancing lung...
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...